CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
(RTTNews) - Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, on Monday, provided an update on a biomarker analysis from its phase II SHINE study of CT1812in ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...
The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...
The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results